Efficacy of the Speech Intelligibility Index as an intervention tool with pediatric cancer patients

This study evaluates the Speech Intelligibility Index (SII) as a tool to describe hearing loss and predict when hearing aids would be appropriate for pediatric oncology patients who have received or are currently receiving cisplatin. The efficacy of the SII is compared to the Brock grade which is commonly used for patients with ototoxic hearing loss secondary to cisplatin treatment. The SII is a discrete measure that precisely reflects the patient’s functional hearing status and is highly correlated with the need for audiologic intervention.

Difference between default telecoil and programmed microphone frequency response in behind-the-ear hearing aids

The notion that the default telecoil (t-coil) frequency response should match the programmed microphone frequency response to provide optimal telephone understanding for hearing aid patients has received little attention. This study addresses differences in the average frequency response of the two transducers in behind-the-ear (BTE) hearing aids.